Kasliwal Manish Kumar, Kale Shashank Sharad, Gupta Aditya, Kiran Narayanam Anantha Sai, Sharma Manish Singh, Agrawal Deepak, Sharma Bhawani Shanker, Mahapatra Ashok K
Department of Neurosurgery and Gamma Knife, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.
Clin Neurol Neurosurg. 2008 Sep;110(8):804-9. doi: 10.1016/j.clineuro.2008.05.004. Epub 2008 Jun 24.
Radiosurgery has been widely adopted for the treatment of cerebral AVMs. However radiosurgical treatment of patients with hemorrhagic presentation is fraught with risk of rebleed during latency period. The present study intends to analyze the obliteration rate, time to obliteration and chances of rebleed in patients with hemorrhagic versus non-hemorrhagic clinical presentation in cerebral arteriovenous malformations (AVMs) treated with gamma knife radiosurgery (GKS).
Of all the patients with cerebral AVMs treated from May 1997 to June 2006, 157 patients with neuroimaging follow up with digital subtraction angiography harboring 160 AVM nidii formed the study group. The mean age of presentation was 28 years (range, 6-58 years); mean nidus volume being 3.64 cm3 (range, 0.011-36.6 cm3). The mean follow up period was 70 months (range, 13-121 months). All the patients were treated predominantly by primary GKS with use of adjunctive pre-GKS embolization in selected patients.
A total of 103 (64%) patients presented with hemorrhage. There was no difference in the obliteration rate (69% versus 67%, p=0.672), mean latency period to obliteration (30 months versus 32 months, p=0.1989) and chances of hemorrhage (4.8% versus 3.5%, p=0.690) in patients with hemorrhagic as compared to non-hemorrhagic presentation.
Prior hemorrhage does not affect the outcome after GKS in terms of obliteration rate, latency to obliteration as well as chances of hemorrhage during latency period. Gamma knife appears equally efficacious irrespective of the mode of clinical presentation in the management of cerebral AVMs; a concomitant use of pre-GKS embolization/surgery may be needed in patients with hemorrhagic presentation in selected cases, however.
放射外科已被广泛用于治疗脑动静脉畸形(AVM)。然而,对有出血表现的患者进行放射外科治疗在潜伏期存在再出血风险。本研究旨在分析接受伽玛刀放射外科(GKS)治疗的脑动静脉畸形(AVM)患者中,有出血与无出血临床表现者的闭塞率、闭塞时间及再出血几率。
在1997年5月至2006年6月接受治疗的所有脑AVM患者中,157例经数字减影血管造影进行神经影像学随访且有160个AVM病灶的患者组成了研究组。平均就诊年龄为28岁(范围6 - 58岁);平均病灶体积为3.64 cm³(范围0.011 - 36.6 cm³)。平均随访期为70个月(范围13 - 121个月)。所有患者主要接受初次GKS治疗,部分患者在GKS前辅助进行栓塞治疗。
共有103例(64%)患者有出血表现。有出血表现的患者与无出血表现的患者相比,在闭塞率(69%对67%,p = 0.672)、平均闭塞潜伏期(30个月对32个月,p = 0.1989)及出血几率(4.8%对3.5%,p = 0.690)方面无差异。
既往出血在闭塞率、闭塞潜伏期及潜伏期出血几率方面不影响GKS后的治疗效果。伽玛刀在治疗脑AVM时,无论临床表现形式如何似乎同样有效;然而,在某些特定有出血表现的患者中可能需要同时使用GKS前栓塞/手术治疗。